SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-19-041213
Filing Date
2019-02-14
Accepted
2019-02-14 17:30:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d691310dsc13g.htm SC 13G 39840
  Complete submission text file 0001193125-19-041213.txt   41661
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Subject) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-47575 | Film No.: 19608607
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10

Mailing Address BAHNHOFSTRASSE 45 ZURICH V8 CH-8001
Business Address BAHNHOFSTRASSE 45 ZURICH V8 CH-8001 41-44-234-1111
UBS Group AG (Filed by) CIK: 0001610520 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G
SIC: 6021 National Commercial Banks
Assistant Director 7